Deutsche Bank Aktiengesellschaft Upgrades Acadia Healthcare (NASDAQ:ACHC) to Buy

Acadia Healthcare (NASDAQ:ACHC) was upgraded by equities researchers at Deutsche Bank Aktiengesellschaft from a “hold” rating to a “buy” rating in a report issued on Thursday, MarketBeat Ratings reports. The brokerage currently has a $75.00 price target on the stock, up from their previous price target of $45.00. Deutsche Bank Aktiengesellschaft’s target price would indicate a potential upside of 84.46% from the stock’s current price.

ACHC has been the topic of several other reports. StockNews.com downgraded Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Friday, November 22nd. Royal Bank of Canada cut their target price on shares of Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a research report on Monday, November 18th. Barclays reduced their price target on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a research report on Friday, November 22nd. KeyCorp started coverage on shares of Acadia Healthcare in a research note on Friday, October 11th. They set a “sector weight” rating on the stock. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $52.00 target price on shares of Acadia Healthcare in a report on Tuesday. One research analyst has rated the stock with a sell rating, three have issued a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, Acadia Healthcare presently has an average rating of “Moderate Buy” and a consensus price target of $75.44.

Acadia Healthcare Stock Performance

Shares of ACHC stock opened at $40.66 on Thursday. The company has a market capitalization of $3.78 billion, a P/E ratio of 13.33, a PEG ratio of 1.77 and a beta of 1.29. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The stock has a 50 day moving average price of $45.39 and a two-hundred day moving average price of $61.82. Acadia Healthcare has a fifty-two week low of $36.50 and a fifty-two week high of $87.77.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. The firm had revenue of $815.60 million for the quarter, compared to analyst estimates of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The company’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.91 EPS. Analysts expect that Acadia Healthcare will post 3.38 earnings per share for the current year.

Institutional Investors Weigh In On Acadia Healthcare

Several large investors have recently modified their holdings of ACHC. GAMMA Investing LLC lifted its position in Acadia Healthcare by 57.1% during the third quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock valued at $42,000 after acquiring an additional 241 shares during the last quarter. Blue Trust Inc. grew its position in Acadia Healthcare by 86.1% during the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company’s stock worth $36,000 after purchasing an additional 248 shares during the last quarter. Commonwealth Equity Services LLC increased its position in shares of Acadia Healthcare by 3.5% in the 2nd quarter. Commonwealth Equity Services LLC now owns 7,595 shares of the company’s stock valued at $513,000 after acquiring an additional 257 shares during the period. Atria Investments Inc increased its holdings in shares of Acadia Healthcare by 4.7% in the third quarter. Atria Investments Inc now owns 6,844 shares of the company’s stock valued at $434,000 after purchasing an additional 308 shares during the period. Finally, KBC Group NV increased its holdings in Acadia Healthcare by 14.4% in the 3rd quarter. KBC Group NV now owns 2,688 shares of the company’s stock worth $170,000 after buying an additional 338 shares during the period.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.